Open Access

On-line plasma lactate concentration monitoring in critically ill patients

  • Christian De Tymowski1,
  • Sabri Soussi1,
  • François Depret1 and
  • Matthieu Legrand1, 2, 3Email author
Critical Care201721:151

https://doi.org/10.1186/s13054-017-1738-6

Published: 16 June 2017

Keywords

Lactate Monitoring Clearance Microdialysis

Blood lactate concentration (BLC) is widely used to guide resuscitation in critically ill patients [1]. Muscular microdialysis has previously been used illustrate the importance of the Na/K pump in hyperlactatemia in septic shock patients [2], with BLC reflecting metabolic changes rather than oxygen debt [3]. Microdialysis has now also been applied to intravascular continuous monitoring [4] (Eirus TLC®, Maquet Critical Care, Solna, Sweden). Nevertheless, the potential clinical implications of on-line lactate monitoring are unclear. In this regard, we illustrate the high sensitivity of the device to detect BLC variations and the potential clinical implications of this.

An adult patient presented with a total body surface area burn of 70% after a suicide attempt by self-immolation. A triple-lumen central venous catheter (CVC) with an integrated microdialysis function was placed in the left internal jugular vein. A second CVC was placed in the right femoral vein. Figure 1 shows BLC variation during the first hours after resuscitation. On top of the general trend of BLC assessment, we propose an alternative additional use of continuous BLC monitoring, namely assessment of blood lactate clearance [5]. A short-lasting rise in BLC can be identified in the global trends (circles in Fig. 1a) corresponding to fluid challenges using Ringer lactate (RL; 500 ml, lactate 29 mmol/L, amount of lactate 14.5 mmol). Lactate clearance can be assessed using the flowing formula: Lc (L/kg/h) = D (mmol/kg)⁄AUC (mmol/L/h), where Lc is lactate clearance, D is the amount of L-lactate infused, and AUC is the area under the curve from RL infusion until BLC reaches its initial level. Two RL bolus infusions via the femoral CVC performed with a 2-h interval (Fig. 1b) allowed us to evaluate lactate clearance at 934 and 1172 ml/min, respectively [5]). The AUC was calculated by the trapezoid method, i.e., the sum of BLC means every minute, with the BLC at initiation of the RL infusion used as the reference (Fig. 1c). Lactate production was calculated to be 3518 and 3176 μmol/kg/h, respectively, as lactate production (μmol/kg/h) = blood lactate (mmol/L) × lactate clearance (mL/kg/h) [5]. Inter-measurement variability was 16 and 7%, respectively, for lactate production and clearance.
Fig. 1

Panel (a) Continous plasma lactate monitoring showing changes in lactate level over the first 65 h. Circles indicate Ringer lactate boluses. Panel (b) Zoom on changes induced by 2 boluses of Ringer lactate (500ml). Panel (c) Area under the curve of plasma lactate during and after infusion of 500 Ringer lactate (Bolus A of panel b)

To summarize, this case illustrates that continuous monitoring could allow sensitive detection of rapid and short-lasting changes in BLC after a 500-ml RL infusion. This could be used to assess lactate clearance. Further studies are needed to validate this concept.

Abbreviations

AUC: 

Area under the curve

BLC: 

Blood lactate concentration

CVC: 

Central venous catheter

D: 

Amount of L-lactate infused

Lc: 

Lactate clearance

RL: 

Ringer lactate

Declarations

Acknowledgements

None.

Funding

This study was not funded.

Availability of data and materials

Figure 1 is original and has never been published.

Authors’ contributions

CDT, SS, and ML collected and analyzed the data and drafted the manuscript. FD helped to draft the manuscript. All authors read and approved the final manuscript.

Authors’ information

Matthieu Legrand is the guarantor of the content of the manuscript, including the data and analysis.

Competing interests

All authors have disclosed that they have no conflicts of interest and have not received any funding related to this work.

Ethics approval and consent to participate

The study was approved by our local ethics committee (comité de protection des personnes IV, St-Louis hospital; Institutional review board 00003835, protocol 2013/17NICB). Informed consent was waived by the ethics committee as this is a non-interventional study. We have removed details pertaining to age and sex from the manuscript so as not to compromise the anonymity of the patient.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
AP-HP, GH St-Louis-Lariboisière, Department of Anesthesiology and Critical Care and Burn Unit, St-Louis Hospital, Assistance Publique- Hopitaux de Paris
(2)
University Paris Diderot
(3)
UMR INSERM 942, Institut National de la Santé et de la Recherche Médicale (INSERM), Lariboisière hospital Univ Paris Diderot

References

  1. Jansen TC, van Bommel J, Schoonderbeek FJ, Sleeswijk Visser SJ, van der Klooster JM, Lima AP, et al. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med. 2010;182:752–61.View ArticlePubMedGoogle Scholar
  2. Levy B, Gibot S, Franck P, Cravoisy A, Bollaert P-E. Relation between muscle Na + K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet. 2005;365:871–5.View ArticlePubMedGoogle Scholar
  3. Garcia-Alvarez M, Marik P, Bellomo R. Sepsis-associated hyperlactatemia. Crit Care. 2014;18:503.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Schierenbeck F, Nijsten MWN, Franco-Cereceda A, Liska J. Introducing intravascular microdialysis for continuous lactate monitoring in patients undergoing cardiac surgery: a prospective observational study. Crit Care. 2014;18:R56.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Levraut J, Ciebiera J-P, Chave S, Rabary O, Jambou P, Carles M, et al. Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction. Am J Respir Crit Care Med. 1998;157:1021–6.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement